Immunohematology In-Vitro Testing Reagents
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- W81K0223Q0092
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Joint Base Lewis McChord, Washington 98431, United States
Notice details come from SAM.gov. Updated .
Notice text
Presolicitation Notice to award under Solicitation: W81K0223Q0092
Pursuant to FAR Subpart 13.106-1(b) (1), the U.S. Army, MEDCOM, Medical Readiness Contracting Office-Pacific Joint Base Lewis-McChord, Health Contracting Branch, Lacey, WA, intends to issue a sole source firm-fixed price award under solicitation W81K0223Q0092 to Immucor, Inc., in the amount of $66,381.78 for follow-on Base +2 years, Invitro Immunohematology Reagents that are used to detect blood typing and identify antibodies in patient specimens. This testing will include rare Anti-Serum for the Fetal Maternal Hemorrhages Screening Kits, which is proprietary to Immucor Inc, at Madigan Army Medical Center Tacoma WA.
This notice is not a request for proposal and a solicitation will not be issued. Any vendor that believes it can provide the stated supplies/equipment can provide supporting documents demonstrating their products capability and specifications. Responses received will be used for future acquisitions. Information can be sent to the Purchasing Agent; Mr. Walter J. Bischoff, email; walter.j.bischoff.civ@health.mil . No telephone or facsimile requests will be accepted. This procurement will be prepared in accordance with FAR Part 13, using Simplified Acquisition Procedures.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Immunohematology In-Vitro Testing Reagents | Award Notice | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity